Quantcast

Thursday 6/13 Insider Buying Report: FFNW, VNRX


Shutterstock photo

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy - they expect to make money. So let's look at two noteworthy recent insider buys.

At First Financial Northwest, a filing with the SEC revealed that on Wednesday, Director Kevin D. Padrick bought 17,540 shares of FFNW, for a cost of $15.05 each, for a total investment of $263,911. First Financial Northwest is trading up about 1.4% on the day Thursday. Before this latest buy, Padrick purchased FFNW at 7 other times during the past year, for a total cost of $710,142 at an average of $15.03 per share.

And on Tuesday, Director Martin Charles Faulkes bought $246,134 worth of VolitionRx, buying 79,269 shares at a cost of $3.10 a piece. Before this latest buy, Faulkes made one other buy in the past twelve months, purchasing $213,608 shares at a cost of $3.02 each. VolitionRx is trading down about 0.7% on the day Thursday. Bargain hunters are able to buy VNRX even cheaper than Faulkes did, with the stock trading as low as $2.90 in trading on Thursday which is 6.6% below Faulkes's purchase price.

Thursday 6/13 Insider Buying Report: FFNW, VNRX VIDEO: Thursday 6/13 Insider Buying Report: FFNW, VNRX

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , Stocks
Referenced Symbols: FFNW , VNRX



More from BNK Invest

Subscribe







BNK Invest
Contributor:

BNK Invest

Market News, Investing












Research Brokers before you trade

Want to trade FX?